PVCT 8-K 2026-06-22

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) 8-K dated 2026-06-22 — accession 0001493152-26-029512.

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) is a biotechnology company listed on OTCQB.

PROVECTUS BIOPHARMACEUTICALS, INC. filed a 8-K on 2026-06-22. Accession 0001493152-26-029512.

This 8-K covers: Shareholder vote results (Item 5.07). SEC EDGAR holds the official filing and its exhibits.

Latest reported PVCT revenue for 2025-09-30 was $336.1K. Net income was -$1.3M. PVCT currently screens at market cap $25.9M.

Not investment advice. The PVCT SEC hub lists recent forms. The stock page is the research view.